citalopram has been researched along with carbostyril in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 20 (66.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Padala, KP; Padala, PR; Sadiq, HJ | 1 |
| Demirdaş, A; Eren, I; Naziroğlu, M | 1 |
| Brahm, NC; Brown, RC; McElwain, DL | 1 |
| Klein, J; Krüger, S; Sarkar, R | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Denninger, JW; Dording, C; Fava, M; Hilliker, S; Homberger, C; Matthews, JD; Park, L; Rooney, K; Siefert, C; Sklarsky, K; van Nieuwenhuizen, AO | 1 |
| Butters, MA; Dew, MA; Driscoll, HC; Lenze, EJ; Miller, MD; Mulsant, BH; Pollock, BG; Reynolds, CF; Sheffrin, M | 1 |
| Blier, P; Chernoloz, O; El Mansari, M | 1 |
| Hedlund, PB; Roberts, AJ; Sarkisyan, G | 1 |
| Anghelescu, I; Born, C; Langosch, J; Luborzewski, A; Quante, A; Schommer, N; Wolf, J; Zeugmann, S | 1 |
| Greenway, LL; Kuppuswamy, PS; Lauterbach, EC | 1 |
| Bruzek, JL; Jerome, RN; Krishnaswami, S; McPheeters, ML; Sathe, N; Veenstra-Vanderweele, J; Warren, Z | 1 |
| Bundgaard, C; Garmer, M; Jensen, CJ | 1 |
| Bou Khalil, R; Dahdah, P; Kahn, DA; Richa, S | 1 |
| Pomeraniec, F; Primeau, M; Wallace, DM | 1 |
| Dimitrakopoulos, S; Kollias, K; Konstantakopoulos, G; Oulis, P; Tsaltas, E | 1 |
| Choi, JE; Han, DH; Kim, SM; Min, KJ; Renshaw, PF | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Banerjee, R; Liu, JJ; Minhas, HM | 1 |
| Chibnall, JT; Conway, CR; Cornell, ME; Cumming, P; Gangwani, S; Gebara, MA; McConathy, JE; Mintun, MA; Perantie, DC; Price, JL; Sheline, YI | 1 |
| Yalcin, O | 1 |
| Chen, TT; Huang, WL; Tsai, CH | 1 |
| Begley, A; Butters, MA; Koenig, AM; Ogbagaber, S; Reynolds, CF; Wahed, AS | 1 |
| Andrews, G; Boulton, M; Michael, S | 1 |
| Hou, YC; Lai, CH | 1 |
| Kagawa, S; Kondo, T; Mihara, K; Nagai, G; Nakamura, A; Nemoto, K; Suzuki, T | 1 |
| Björkholm, C; Jardemark, K; Konradsson-Geuken, Å; Marcus, MM; Svensson, TH | 1 |
| O'Connor, M | 1 |
| Mishra, VC; Swami, MK | 1 |
2 review(s) available for citalopram and carbostyril
| Article | Year |
|---|---|
A systematic review of medical treatments for children with autism spectrum disorders.
Topics: Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Child, Preschool; Citalopram; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Fluoxetine; Humans; Male; Patient Compliance; Piperazines; Prognosis; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Serotonin Antagonists; Severity of Illness Index; Treatment Outcome | 2011 |
Lycanthropy as a culture-bound syndrome: a case report and review of the literature.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Behavior Control; Citalopram; Cultural Characteristics; Culture; Delusions; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Ethnopsychology; Female; Humans; Lebanon; Middle Aged; Mythology; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2012 |
7 trial(s) available for citalopram and carbostyril
| Article | Year |
|---|---|
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duloxetine Hydrochloride; Feasibility Studies; Female; Humans; Male; Personality Inventory; Pilot Projects; Piperazines; Quinolones; Thiophenes; Venlafaxine Hydrochloride | 2009 |
Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo-controlled pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antimanic Agents; Aripiprazole; Bipolar Disorder; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2010 |
Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.
Topics: Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Functional Neuroimaging; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurons; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Selective Serotonin Reuptake Inhibitors | 2013 |
Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.
Topics: Adult; Animals; Antidepressive Agents; Aripiprazole; Caudate Nucleus; Citalopram; Corpus Striatum; Depressive Disorder, Major; Dihydroxyphenylalanine; Dopamine; Dopamine Agonists; Drug Synergism; Female; Humans; Magnetic Resonance Imaging; Male; Piperazines; Positron-Emission Tomography; Quinolones; Sample Size; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2014 |
Effects of escitalopram on plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients.
Topics: Adult; Aripiprazole; Asian People; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Electrocardiography; Electroencephalography; Female; Genotype; Humans; Male; Mental Disorders; Middle Aged; Paroxetine; Piperazines; Quinolones | 2014 |
21 other study(ies) available for citalopram and carbostyril
| Article | Year |
|---|---|
Urinary obstruction with citalopram and aripiprazole combination in an elderly patient.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Citalopram; Drug Therapy, Combination; Humans; Male; Piperazines; Quinolones; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Urinary Retention | 2006 |
Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Ascorbic Acid; beta Carotene; Brain; Calcium Channel Blockers; Citalopram; Glutathione; Glutathione Peroxidase; Lamotrigine; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Piperazines; Quinolones; Random Allocation; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Triazines; Vitamin A | 2007 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; Diphenhydramine; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Oxazepam; Piperazines; Quinolones | 2007 |
Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Topics: Antipsychotic Agents; Aripiprazole; Chronic Disease; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Stereotyped Behavior | 2008 |
An open study of aripiprazole and escitalopram for psychotic major depressive disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Selective Serotonin Reuptake Inhibitors | 2009 |
Electrophysiological studies in the rat brain on the basis for aripiprazole augmentation of antidepressants in major depressive disorder.
Topics: Action Potentials; Analysis of Variance; Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Brain; Citalopram; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Lysergic Acid Diethylamide; Male; Neurons; Norepinephrine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Time Factors | 2009 |
The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Corticosterone; Depression; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Hindlimb Suspension; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Phenols; Piperazines; Quinolones; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides; Swimming | 2010 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors | 2010 |
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride | 2012 |
Serotonin toxicity in aripiprazole augmentation.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Cyproheptadine; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2012 |
Low-dose aripiprazole in the treatment of SSRI-induced bruxism.
Topics: Antipsychotic Agents; Aripiprazole; Bruxism; Citalopram; Female; Humans; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2012 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
Lyme neuroborreliosis presenting with alexithymia and suicide attempts.
Topics: Adult; Affective Symptoms; Anti-Bacterial Agents; Antibodies, Bacterial; Antipsychotic Agents; Aripiprazole; Borrelia; Ceftriaxone; Citalopram; Hospitalization; Humans; Injections, Intravenous; Intelligence Tests; Interview, Psychological; Lyme Neuroborreliosis; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Treatment Outcome | 2013 |
Micturition difficulty and urinary retention associated with aripiprazole and citalopram treatment in a male adolescent with Asperger syndrome.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Citalopram; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Urinary Retention; Urination Disorders | 2014 |
Combination of escitalopram and aripiprazole causes significant improvement of negative symptoms of simple schizophrenia.
Topics: Aripiprazole; Citalopram; Drug Therapy, Combination; Female; Humans; Middle Aged; Piperazines; Quinolones; Schizophrenia; Treatment Outcome | 2014 |
Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning.
Topics: Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Citalopram; Cognitive Dysfunction; Cyclohexanols; Dementia; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2014 |
Two cases of olfactory reference syndrome responding to an atypical antipsychotic and SSRI.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Piperazines; Quinolones; Risperidone; Selective Serotonin Reuptake Inhibitors; Young Adult | 2014 |
Rapid responses of high-dose combined therapy of escitalopram and aripiprazole in a case of severe obsessive compulsive disorder with delusion.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Delusions; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Young Adult | 2014 |
The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism.
Topics: Animals; Citalopram; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Electric Stimulation; Excitatory Postsynaptic Potentials; Glutamic Acid; In Vitro Techniques; Male; Neurotransmitter Agents; Patch-Clamp Techniques; Prefrontal Cortex; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Thiophenes | 2017 |
Adjunctive therapy with brexpiprazole improves treatment resistant complex post traumatic stress disorder in domestic family violence victims.
Topics: Adult; Citalopram; Combined Modality Therapy; Desvenlafaxine Succinate; Domestic Violence; Drug Resistance; Drug Therapy, Combination; Female; Humans; Middle Aged; Psychotherapy; Quinolones; Stress Disorders, Post-Traumatic; Thiophenes | 2020 |
Interest-Activity Dimension and Response to Aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Citalopram; Depressive Disorder, Major; Humans; Quinolones | 2020 |